Effects of pravastatin on diabetic cardiomyopathy according to the blood glucose control in type 1 diabetic rats
제1형 당뇨 쥐에서 혈당 조절에 따라 프라바스타틴의 복용이 당뇨병성 심근병증의 진행에 미치는 영향

Cited 0 time in Web of Science Cited 0 time in Scopus
의과대학 의학과
Issue Date
서울대학교 대학원
학위논문 (박사)-- 서울대학교 대학원 : 의과대학 의학과, 2018. 8. 전윤석.
Background: Although statins have been suggested to attenuate the progression of diabetic cardiomyopathy, it remains unclear whether statins are protective in diabetic hearts when blood glucose is not controlled. We evaluated the effect of pravastatin on diabetic rat hearts according to the presence of glycemic control.

Methods: Seven-week-old male Lewis rats (n = 87) were randomly divided into five groups: control (group C), diabetes (D), diabetes with insulin (I), diabetes with pravastatin (P), and diabetes with insulin and pravastatin (IP). Diabetes was induced using a single intravenous injection of streptozotocin (65 mg/kg). After diagnosing diabetes (blood glucose > 300 mg/dl), insulin (2-10 U/kg, twice a day) and/or pravastatin (20-25 mg/kg/day) were administered depending on the group assignment. Eight weeks after diabetic induction, the heart was extracted following echocardiography. Cardiac fibrosis was analyzed using Massons trichrome stain. Cardiac expression of collagen I/III, matrix metalloproteinase (MMP)-2, MMP-9, and angiotensin converting enzyme (ACE)/ACE2 were evaluated by immunohistochemistry and/or Western blot. Enzyme-linked immunosorbent assay was used for measuring reactive oxygen species (ROS).

Results: Diabetic groups without glycemic control (groups D and P) showed significantly impaired diastolic function and significantly increased levels of cardiac fibrosis, collagen I/III, MMP-2, and MMP-9. ROS production was also significantly increased in groups D and P. However, there were no significant differences in most outcomes among the control and two glucose-controlled diabetic groups (groups I and IP). Cardiac ACE2 expression was more preserved, while ACE expression was lower in groups C and IP than in the other groups (D, I, and P).

Conclusion: Our study suggests that glycemic control using insulin rather than pravastatin attenuates the progression of diabetic cardiomyopathy. However, further study is required to evaluate the usefulness of statins in protecting diabetic hearts.
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Dept. of Medicine (의학과)Theses (Ph.D. / Sc.D._의학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.